GL1X · GenesisL1 explorer

Research workbench

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents

Analyse Identification of novel, potent and selective GCN2 inhibitors as first-in-class… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6N3O
Type
protein
Length
252 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Eif-2-alpha kinase GCN2
EC
2.7.11.1
UniProt
Q9P2K8
Ligands
KA7
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEif-2-alpha kinase GCN2 (EC 2.7.11.1)protein25237% helix, 20% strandQ9P2K8

Ligands and binding sites

  • KA7 · N-{3-[(2-aminopyrimidin-5-yl)ethynyl]-2,4-difluorophenyl}-5-chloro-2-methoxypyridine-3-sulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14360.730.8253KA7

Compared structures

  • 6N3O · Identification of novel, potent and selective GCN2 inhibitors as first-in-class… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9P2K8 · AlphaFold monomer V2.0 prediction for eif-2-alpha kinase GCN2 (Q9P2K8) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.